₹ 597.20
0.40 (0.07%)
C
Concord Biotech
₹ 597.20
CONCORDBIO Financials Summary (Consolidated)
Concord Biotech revenue increased 17.53% quarter-on-quarter to ₹319 Cr in Sep 2026, while net profit increased 20.62% quarter-on-quarter to ₹70 Cr. Compared to the same quarter last year, revenue is up 21.51% and net profit is up 10.30%. EPS for the quarter stood at ₹6.65, increased from ₹5.52 in the previous quarter and up from ₹6.03 a year ago.
Concord Biotech Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of CONCORDBIO Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
CONCORDBIO Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






